Secnidazole — Active Pharmaceutical Ingredient

Secnidazole is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: GRANULE. Routes: ORAL.

This content is for informational purposes only. Always consult a healthcare professional.

Secnidazole (1 brand name, 1 dosage form, 1 route)

Available dosage forms: GRANULE.

Routes of administration: ORAL.

Brand Names

  • SOLOSEC

Contraindications

SOLOSEC is contraindicated: In patients who have shown hypersensitivity to secnidazole, or other nitroimidazole derivatives. In patients with Cockayne syndrome: Severe irreversible hepatotoxicity/acute liver failure with fatal outcomes have been reported after initiation of metronidazole, another nitroimidazole drug, structurally related to secnidazole, in patients with Cockayne syndrome [see Adverse Reactions (6.2)].

Adverse Reactions

The following important adverse reactions are discussed in greater detail in other sections of labeling: Vulvovaginal Candidiasis [Warnings and Precautions (5.1)]

Mechanism of Action

SOLOSEC is a nitroimidazole antimicrobial drug [see Microbiology (12.4)].

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.